Modifying the design of ongoing trials without unblinding.
暂无分享,去创建一个
[1] N L Geller,et al. On the choice of times for data analysis in group sequential clinical trials. , 1991, Biometrics.
[2] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[3] Michael A. Proschan,et al. Effects of assumption violations on type I error rate in group sequential monitoring , 1992 .
[4] Nancy L. Geller. Discussion of ‘interim analysis: The alpha spending approach’ , 1994 .
[5] J M Lachin,et al. Use of spending functions for occasional or continuous monitoring of data in clinical trials. , 1993, Statistics in medicine.
[6] A. Gould. Planning and revising the sample size for a trial. , 1995, Statistics in Medicine.
[7] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[8] A. Gould,et al. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance , 1992 .
[9] A L Gould,et al. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. , 1992, Statistics in medicine.
[10] Edward B. Fowlkes,et al. Some Methods for Studying the Mixture of Two Normal (Lognormal) Distributions , 1979 .
[11] J. Wittes,et al. The role of internal pilot studies in increasing the efficiency of clinical trials. , 1990, Statistics in medicine.
[12] D L DeMets,et al. Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.
[13] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[14] Christopher Jennison,et al. Efficient group sequential tests with unpredictable group sizes , 1987 .
[15] A. Lawrence Gould,et al. Group sequential methods for clinical trials allowing early acceptance of Ho and incorporating costs , 1982 .